Teladoc Health, Inc. logo TDOC - Teladoc Health, Inc.

Price: -- -- | CONSENSUS: Hold DETAILS
STRONG
BUY
0
BUY 14
HOLD 28
SELL 0
STRONG
SELL
0
| PRICE TARGET: $7.58 DETAILS
HIGH: $11.00
LOW: $6.00
MEDIAN: $7.00
CONSENSUS: $7.58
UPSIDE: 15.37%
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Revenue
Revenue 2,530.0 2,569.6 2,602.4 2,406.8 2,032.7 1,094.0 553.3 417.9 233.3 123.2 77.4 43.5 19.9
Cost of Revenue 771.6 751.3 760.0 744.0 650.3 390.8 184.5 128.7 61.6 32.0 21.0 9.9 4.2
Gross Profit 1,758.4 1,818.3 1,842.4 1,662.9 1,382.4 703.1 368.8 289.2 171.7 91.2 56.3 33.6 15.7
Operating Expenses
R&D Expenses 277.9 307.3 348.5 333.6 311.9 164.9 64.6 54.4 34.5 21.8 14.2 7.6 3.5
SG&A Expenses 1,085.3 1,346.3 1,367.3 1,300.6 1,105.3 886.9 339.1 265.2 180.3 113.6 89.3 38.2 17.1
Other Expenses 658.2 1,185.6 375.1 13,681.9 230.9 157.7 45.6 40.5 32.3 18.4 8.6 2.9 1.0
Operating Expenses 2,021.3 2,839.2 2,090.9 15,316.1 1,648.1 1,209.6 449.3 360.0 247.1 153.8 112.1 48.7 21.6
Operating Income
Operating Income (263.0) (1,020.9) (248.6) (13,653.2) (265.6) (506.4) (80.4) (70.9) (75.4) (62.7) (55.8) (15.2) (5.9)
Interest Expense 19.7 23.8 22.3 21.9 81.1 60.0 29.4 26.1 17.5 2.6 2.2 1.5 0.1
Interest Income 36.8 57.1 46.8 12.7 0.8 0 0 0 0 0 0 0 0
Profitability
EBITDA 147.3 31.7 43.6 (7.5) (31.4) (354.5) (34.9) (30.4) (43.1) (44.3) (47.1) (12.2) (4.9)
EBIT (215.8) (208.8) (210.5) (217.5) (239.0) (418.2) (73.8) (66.0) (62.2) (52.5) (52.0) (14.5) (5.7)
Income Before Tax (235.5) (993.7) (219.6) (13,663.3) (384.7) (576.0) (109.5) (97.0) (107.0) (73.7) (58.0) (16.6) (5.9)
Income Tax Expense (35.2) 7.6 0.8 (3.8) 44.1 (90.9) (10.6) 0.1 (0.2) 0.5 0.0 0.4 0.1
Net Income (200.3) (1,001.2) (220.4) (13,659.5) (428.8) (485.1) (98.9) (97.1) (106.8) (74.2) (58.0) (17.0) (6.0)
Per Share Data
EPS (Basic) -1.14 -5.87 -1.36 -84.60 -2.73 -5.36 -1.38 -1.47 -1.93 -1.75 -2.91 -0.62 -0.22
EPS (Diluted) -1.14 -5.87 -1.34 -84.60 -2.73 -5.36 -1.38 -1.47 -1.93 -1.75 -2.91 -0.62 -0.22
Shares Outstanding 176.2 170.6 162.2 161.5 156.9 90.5 71.8 65.8 55.4 42.3 19.9 27.6 27.6
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Current Assets
Cash & Cash Equivalents 781.1 1,298.3 1,123.7 918.2 893.5 733.3 514.4 424.0 42.8 50.0
Short-Term Investments 0 0 0 0 2.5 53.2 2.7 54.5 79.5 15.8
Net Receivables 201.7 224.0 230.1 235.6 190.1 169.3 56.9 43.6 27.1 13.8
Inventory 38.2 38.1 29.5 56.3 73.1 56.5 0 0 0 0
Other Current Assets 2.1 36.0 40.1 12.1 28.0 0 0 10.6 6.8 0
Total Current Assets 1,087.3 1,663.9 1,489.0 1,285.4 1,225.4 1,059.6 588.0 532.7 156.2 82.7
Non-Current Assets
Property, Plant & Equipment 53.1 56.6 72.1 71.5 74.0 75.2 36.7 10.1 9.0 7.5
Goodwill 283.2 283.2 1,073.2 1,073.2 14,504.2 14,581.3 746.1 737.2 498.5 188.2
Intangible Assets 1,297.1 1,431.4 1,677.8 1,836.8 1,910.3 2,020.9 225.5 247.4 159.8 24.9
Long-Term Investments 0 0 0 0 0 0 0 94.0 49.4 0
Other Non-Current Assets 137.6 81.5 80.3 78.5 20.7 18.4 6.5 1.4 0.9 0.4
Total Non-Current Assets 2,013.5 1,852.6 2,903.3 3,415.5 16,509.2 16,695.7 1,014.8 996.1 668.2 221.0
Total Assets 3,100.8 3,516.5 4,392.4 4,701.0 17,734.6 17,755.3 1,602.8 1,528.9 824.4 303.7
Current Liabilities
Account Payables 48.0 33.1 43.6 47.7 47.3 46.0 9.1 7.8 3.9 2.2
Short-Term Debt 11.0 550.7 0 13.6 0 42.6 0 0 0 2
Deferred Revenue 62.3 79.3 95.7 101.8 75.6 52.4 12.5 7.7 4.1 1.0
Other Current Liabilities 187.2 69.3 167.3 151.3 132.2 128.9 39.3 16.5 12.1 5.9
Total Current Liabilities 404.7 941.5 420.6 399.8 331.0 332.6 90.2 62.4 40.3 21.1
Non-Current Liabilities
Long-Term Debt 994.9 991.4 1,538.7 1,535.3 1,225.7 1,379.6 440.4 414.7 207.4 42.4
Deferred Tax Liabilities 271.4 49.9 49.5 406.5 75.8 102.1 21.7 32.4 12.9 1.7
Other Non-Current Liabilities 0.6 0.7 1.1 1.6 10.8 11.5 9.2 6.2 17.8 7.6
Total Non-Current Liabilities 1,310.4 1,083.9 1,645.7 1,993.4 1,357.8 1,538.8 498.6 453.3 225.2 51.7
Total Liabilities 1,715.1 2,025.4 2,066.3 2,393.2 1,688.9 1,871.5 588.8 515.8 265.5 72.8
Stockholders' Equity
Common Stock 0.2 0.2 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.0
Retained Earnings (16,430.2) (16,229.9) (15,228.7) (15,008.3) (1,421.5) (992.7) (507.5) (408.7) (311.6) (204.7)
Accumulated Other Comprehensive Income (34.7) (38.4) (37.0) (42.8) (6.3) 18.5 (17.2) (13.1) 4.1 (0.0)
Total Stockholders' Equity 1,385.7 1,491.1 2,326.1 2,307.7 16,045.8 15,883.8 1,014.0 1,013.1 558.9 230.9
Total Liabilities & Equity 3,100.8 3,516.5 4,392.4 4,701.0 17,734.6 17,755.3 1,602.8 1,528.9 824.4 303.7
Debt Metrics
Total Debt 1,040.2 1,584.6 1,592.3 1,586.9 1,280.1 1,476.7 470.5 414.7 207.4 44.4
Net Debt 259.1 286.3 468.6 668.7 386.7 743.4 (43.9) (9.3) 164.6 (5.6)
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Operating Activities
Net Income (200.3) (1,001.2) (220.4) (13,659.5) (428.8) (485.1) (98.9) (97.1) (106.8) (74.2)
Depreciation & Amortization 363.1 382.8 348.7 270.6 219.6 78.1 45.0 35.6 19.1 8.3
Stock-Based Compensation 80.4 146.0 201.6 0 0 475.5 66.7 43.8 30.6 7.7
Change in Working Capital 1.1 (36.3) 11.6 (61.0) (50.3) (90.5) (1.4) (1.1) 0.7 (4.5)
Other Non-Cash Items 91.5 803.6 10.4 13,647.0 411.7 58.6 29.4 16.2 22.2 10.4
Operating Cash Flow 294.4 293.7 350.0 189.3 194.0 (53.5) 29.9 (4.9) (34.4) (51.8)
Investing Activities
Capital Expenditure (8.9) (10.8) (156.3) (16.5) (8.5) (26.0) (10.9) (8.4) (5.5) (3.4)
Acquisitions (81.9) 0 0 0 (78.7) (567.4) (11.2) (282.4) (379.4) (37.0)
Purchases of Investments 0 0 0 0 0 0 (5) (56.3) (149.3) (44.1)
Sales/Maturities of Investments 0.7 0 0 2.5 60.9 2.5 52.1 84.2 85.8 110.7
Other Investing Activities (175.9) (113.3) 0.0 2.5 8.7 0 (7.4) 5.5 (66.4) 65.3
Investing Cash Flow (266.0) (124.1) (156.3) (167.7) (73.0) (591.0) 25.0 (257.5) (448.4) 26.1
Financing Activities
Net Debt Issuance (550.6) 0 0 (3.1) (0.9) 761.8 0 279.2 204.0 17.8
Stock Repurchased 0 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0
Other Financing Activities (4.1) (0.0) 10.9 (2.7) (0.7) 97.3 35.1 35.6 12.9 2.5
Financing Cash Flow (551.7) 8.3 10.9 6.5 40.9 859.1 35.1 645.6 475.4 20.6
Cash Position
Net Change in Cash (517.2) 174.7 205.5 24.7 160.2 219.0 90.4 381.2 (7.2) (5.1)
Cash at Beginning 1,298.3 1,123.7 918.2 893.5 733.3 514.4 424.0 42.8 50.0 55.1
Cash at End 781.1 1,298.3 1,123.7 918.2 893.5 733.3 514.4 424.0 42.8 50.0
Free Cash Flow 285.5 282.9 193.7 172.8 185.5 (79.6) 19.0 (13.3) (40.0) (55.2)
Key Metrics 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Income Statement
Revenue 2,530.0 2,569.6 2,602.4 2,406.8 2,032.7 1,094.0 553.3 417.9 233.3 123.2 77.4 43.5 19.9
Gross Profit 1,758.4 1,818.3 1,842.4 1,662.9 1,382.4 703.1 368.8 289.2 171.7 91.2 56.3 33.6 15.7
Operating Income (263.0) (1,020.9) (248.6) (13,653.2) (265.6) (506.4) (80.4) (70.9) (75.4) (62.7) (55.8) (15.2) (5.9)
Net Income (200.3) (1,001.2) (220.4) (13,659.5) (428.8) (485.1) (98.9) (97.1) (106.8) (74.2) (58.0) (17.0) (6.0)
EPS (Diluted) -1.14 -5.87 -1.34 -84.60 -2.73 -5.36 -1.38 -1.47 -1.93 -1.75 -2.91 -0.62 -0.22
Balance Sheet
Cash & Equivalents 781.1 1,298.3 1,123.7 918.2 893.5 733.3 514.4 424.0 42.8 50.0
Total Assets 3,100.8 3,516.5 4,392.4 4,701.0 17,734.6 17,755.3 1,602.8 1,528.9 824.4 303.7
Total Debt 1,040.2 1,584.6 1,592.3 1,586.9 1,280.1 1,476.7 470.5 414.7 207.4 44.4
Stockholders' Equity 1,385.7 1,491.1 2,326.1 2,307.7 16,045.8 15,883.8 1,014.0 1,013.1 558.9 230.9
Cash Flow
Operating Cash Flow 294.4 293.7 350.0 189.3 194.0 (53.5) 29.9 (4.9) (34.4) (51.8)
Capital Expenditure (8.9) (10.8) (156.3) (16.5) (8.5) (26.0) (10.9) (8.4) (5.5) (3.4)
Free Cash Flow 285.5 282.9 193.7 172.8 185.5 (79.6) 19.0 (13.3) (40.0) (55.2)